Efficacy of alemtuzumab in cutaneous chronic lymphocytic leukaemia involving facial skin.
作者信息
Grey Mark
机构信息
Department of Haematology, Royal Bolton Hospital, Farnworth, Bolton, UK.
出版信息
Br J Haematol. 2008 Jul;142(1):1. doi: 10.1111/j.1365-2141.2007.06970.x. Epub 2008 May 8.
Abstract
摘要
相似文献
1
Efficacy of alemtuzumab in cutaneous chronic lymphocytic leukaemia involving facial skin.
Br J Haematol. 2008 Jul;142(1):1. doi: 10.1111/j.1365-2141.2007.06970.x. Epub 2008 May 8.
2
Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia.
Br J Haematol. 2007 Jun;137(6):490. doi: 10.1111/j.1365-2141.2007.06580.x. Epub 2007 Apr 11.
3
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
J Clin Oncol. 2008 Nov 10;26(32):5299-301. doi: 10.1200/JCO.2008.18.6270. Epub 2008 Oct 14.
4
Low-dose intravenous alemtuzumab therapy in pretreated patients affected by chronic lymphocytic leukemia. A single center experience.
Haematologica. 2005 Aug;90(8):1143-5.
5
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy.
Lancet Oncol. 2004 Jan;5(1):64-5. doi: 10.1016/s1470-2045(03)01327-5.
6
Atypical presentation of varicella zoster in a patient on alemtuzumab.
Br J Haematol. 2007 Aug;138(4):406. doi: 10.1111/j.1365-2141.2007.06681.x.
7
NCCN: New directions in chronic lymphocytic leukemia.
Cancer Control. 2001 Nov-Dec;8(6 Suppl 2):114-7.
8
Alemtuzumab in chronic lymphocytic leukemia.
Future Oncol. 2007 Feb;3(1):29-42. doi: 10.2217/14796694.3.1.29.
9
Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation.
Leukemia. 2006 Dec;20(12):2204-7. doi: 10.1038/sj.leu.2404435. Epub 2006 Oct 19.
10
Advances in the use of alemtuzumab in CLL.
Clin Adv Hematol Oncol. 2008 Jan;6(1):23-4.
Zotero 插件